MedTrace Logo

Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study

NCT01956435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2017-12-02

Study results available
· View outcomes & findings →

Summary

This pilot study will consist of 10 adult subjects with symmetric idiopathic guttate hypomelanosis on the lower legs. Subjects will be randomized to which extremity (right or left) will be treated. Treatments with the Xtrac Excimer laser will be performed twice weekly for 12 weeks using the typical vitiligo protocol. Our goal is to determine the effectiveness of excimer laser for repigmentation of idiopathic guttate hypomelanosis. Effectiveness will be graded by the blinded observer scale via photographic comparisons and will be graded by subject via survey every 4 weeks.

Conditions

  • Idiopathic Guttate Hypomelanosis

Interventions

DEVICE

Excimer Light Treatment

Excimer light treatment will be performed on one leg of every subject as the intervention while the subjects other leg will serve as a control

Sponsors & Collaborators

  • American Society of Dermatologic Surgeons

    collaborator UNKNOWN

  • Photomedex

    collaborator UNKNOWN

  • Seton Healthcare Family

    lead OTHER

Principal Investigators

  • Ammar Ahmed, MD · Seton Healthcare Family

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-06-30
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01956435 on ClinicalTrials.gov